Voriconazole Plasma Concentrations in Immunocompromised Pediatric Patients Vary by <i>CYP2C19</i> DiplotypesJ. Kevin Hicks, Mary V. Relling, Calvin C. Daniels et al.|Pharmacogenomics|2014Cited by 68
Posaconazole Therapeutic Drug Monitoring in Pediatric Patients and Young Adults with CancerValeria Bernardo, William L. Greene, Shane J. Cross et al.|Annals of Pharmacotherapy|2013Cited by 58